Dicerna Pharmaceuticals (DRNA) Appoints Dr. Pankaj Bhargava As Chief Medical Officer
4/3/2014 8:50:38 AM
Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced the appointment of Pankaj Bhargava, M.D., as Chief Medical Officer. Dr. Bhargava brings to Dicerna more than 15 years of experience in oncology drug development and translational research gained in leading industry and academic institutions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by